Aptevo Therapeutics Inc.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Dec 2014 | — | $94.6M | $3.6M |
| Jun 2015 | — | — | $4.1M |
| Sep 2015 | — | — | $3.5M |
| Dec 2015 | — | $88.6M | $4.6M |
| Mar 2016 | — | $89.9M | $3.1M |
| Jun 2016 | — | $97.2M | $5.5M |
| Sep 2016 | $18.1M | $63.8M | $10.9M |
| Dec 2016 | $18.4M | $50.6M | $9.7M |
| Mar 2017 | $18.4M | $61.5M | $14.0M |
| Jun 2017 | $18.7M | $51.4M | $22.3M |
| Sep 2017 | $17.5M | $90.3M | $75.8M |
| Dec 2017 | $15.7M | $82.0M | $7.1M |
| Mar 2018 | $14.0M | $68.4M | $11.8M |
| Jun 2018 | $15.4M | $56.0M | $7.2M |
| Sep 2018 | $19.1M | $44.0M | $28.4M |
| Dec 2018 | $19.3M | $30.4M | $30.6M |
| Mar 2019 | $19.4M | $39.1M | $37.0M |
| Jun 2019 | $19.6M | $26.2M | $21.0M |
| Sep 2019 | — | $19.7M | $17.7M |
| Dec 2019 | — | $11.8M | $12.4M |
| Mar 2020 | — | $15.2M | $12.3M |
| Jun 2020 | — | $8.7M | $7.6M |
| Sep 2020 | — | $2.2M | $24.9M |
| Dec 2020 | $28.2M | $16.6M | $40.0M |
| Mar 2021 | — | $10.5M | $57.5M |
| Jun 2021 | — | $13.9M | $60.4M |
| Sep 2021 | — | $7.3M | $52.1M |
| Dec 2021 | $3.7M | $1.2M | $45.0M |
| Mar 2022 | — | $-5.9M | $35.0M |
| Jun 2022 | — | $23.0M | $29.4M |
| Sep 2022 | $1.9M | $15.8M | $22.2M |
| Dec 2022 | $1.5M | $18.0M | $22.6M |
| Mar 2023 | $0 | $23.3M | $25.3M |
| Jun 2023 | $0 | $16.3M | $21.0M |
| Sep 2023 | $0 | $14.7M | $19.1M |
| Dec 2023 | $0 | $12.2M | $16.9M |
| Mar 2024 | — | $6.1M | $10.3M |
| Jun 2024 | — | $4.5M | $8.1M |
| Sep 2024 | — | $4.4M | $7.8M |
| Dec 2024 | — | $4.8M | $8.7M |
| Mar 2025 | — | $-1.5M | $2.1M |
| Jun 2025 | — | $6.5M | $9.4M |
| Sep 2025 | — | $17.4M | $21.1M |
| Dec 2025 | — | $17.4M | $21.6M |
| Mar 2026 | — | $11.6M | $14.5M |
| Jun 2026 | — | $6.0M | $9.8M |